Figure 5From: Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer Mechanistic assessment of the effect of CHKA in modulating response to aromatase inhibitor (AI) therapy. (A) Following RNA-interference-mediated silencing of CHKA, SUM44 cells were transfected with an estrogen receptor (ER)/ERE luciferase reporter construct, and then treated with E2 or dextran charcoal-stripped media (DCC) for 2 days before reading luciferase activity. Data are normalized to the activity in the DCC-treated control transfected cell lines. *Significant P-value (<0.05) between the indicated column and corresponding siControl-equivalent. (B) To validate effects seen with the ER-ERE reporter assay, expression levels of two well known ER-regulated genes (TFF1 and GREB1) were assessed by quantitative real-time PCR following RNA-interference-induced silencing of CHKA. Data normalized to DCC-treated control transfected cell lines; *P-value <0.01 between indicated column and corresponding siCON equivalent. (C) Following RNA-interference-induced silencing of CHKA, cell lysates were subjected to gel electrophoresis and western blotting using indicated antibodies. Cells were treated with 1nM E2 for 1 h or 24 h following transfection, to represent the two phases of ER dynamics (early active- and late turnover phase). Blots are representative of at least two independent experiments; numbers below each band represent densitometry analysis of intensity, measured as a ratio of the siControl with no siCHKA or E2 treatments.Back to article page